Kangtai Bio: It is proposed to repurchase not less than 100 million yuan and no more than 200 million yuan.

Every time AI News, Kangtai Bio (SZ 300601, closing price: 32.22 yuan) issued an announcement on the evening of September 14, saying that on August 18, 2022, the fifth session of the company's seventh board "Proposal to repurchase the company's shareholding plan", the board of directors agreed that the company used its own funds to repurchase some RMB ordinary A -share shares by concentrated bidding transactions. It is the company's issued RMB ordinary shares (A shares). The total amount of funds repurchased this time is not less than RMB 100 million (including) and no more than RMB 200 million (inclusive). The repurchase price does not exceed RMB 55/share (including). The implementation period of this repurchase shares is within 6 months from the date of the shareholders meeting of Shenzhen Kangtai Biological Products Co., Ltd. to review and approve the repurchase share plan.

From January to December 2021, the operating income of Kangtai Bio was 99.94%of biological products.

The chairman of Kangtai Bio is Du Weimin, male, 59 years old, and his academic background is a master's degree. The president is Miao Xiang, male, 49 years old, and his academic background is a master's degree.

As of press time, Kangtai's biological market value was 36.1 billion yuan.

Daeda1997 "Single Stock Trends" reminder:

1. Kangtai Biosciences have decreased by 6.5157 million shares in the north within 30 days, accounting for 0.75%of the proportion of circulating shares;

2. Insexual investigation of Kangtai Bio has not been made in the past 30 days.

For more stock trend information, please search for the WeChat public account "Daida", reply "Query", and receive free query permissions!

Every headline (NBDTOUTIAO) -Challenge Qualcomm 8155 domestic "core" hopes

(Reporter Zeng Jianhui)

Disclaimer: The content and data of this article are for reference only, and do not constitute investment suggestions. Please verify before use. Based on this, the risk is on its own.

Daily Economic News

- END -